It was also reported that some drugs with antitumor activity, such as R-2-hydroxyglutarate (R-2HG), inhibited proliferation/survival of FTO-high cancer cells via targeting FTO/m6A/MYC/CEBPA signaling (Su et al., 2018). This evidence concerns the gene MYC and cancer.